Top

BMC Nephrology

Published in:

01-12-2022 | IgA Vasculitis | Research

Intestinal dysbiosis featuring abundance of Streptococcus associates with Henoch-Schönlein purpura nephritis (IgA vasculitis with nephritis) in adult

Authors: Jiaxing Tan, Zhengxia Zhong, Yi Tang, Wei Qin

Published in: BMC Nephrology | Issue 1/2022

Abstract

Background

The pathogenesis of Henoch-Schönlein purpura nephritis (HSPN) is closely associated with mucosal infection. But whether intestinal microbiota dysbiosis plays a role in it is not clear.

Methods

A total of 52 participants including 26 HSPN patients and 26 healthy controls were included. By using 16S ribosomal RNA gene sequencing, the intestinal microbiota composition between HSPN and healthy controls was compared. The diagnostic potency was evaluated by Receiver operating characteristic (ROC) with area under curves (AUC). Meanwhile, correlation analysis was also performed.

Results

The lower community richness and diversity of fecal microbiota was displayed in HSPN patients and the structure of gut microbiota was remarkedly different. A genus-level comparison indicated a significant increase in the proportions of g-Bacteroides, g-Escherichia–Shigella and g-Streptococcus, and a marked reduction of g-Prevotella_9 in HSPN patients, suggesting that the overrepresentation of potential pathogens and reduction of profitable strains were the main feature of the dysbiosis. The differential taxonomic abundance might make sense for distinguishing HSPN from healthy controls, with AUC of 0.86. The relative abundance of the differential bacteria was also concerned with clinical indices. Among them, Streptococcus spp. was positively associated with the severity of HSPN (P < 0.050). It was found that HSPN patients with higher level of Streptococcus spp. were more likely to suffering from hematuria and hypoalbuminemia (P < 0.050).

Conclusions

The dysbiosis of gut microbiota was obvious in HSPN patients, and the intestinal mucosal streptococcal infection was distinctive, which was closely related to its severity.

Available only for authorised users

Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197–202. https://doi.org/10.1016/s0140-6736(02)11279-7.CrossRefPubMed

N. Ruperto, S. Ozen, A. Pistorio, P. Dolezalova, P. Brogan, D. A. Cabral, R. Cuttica, R. Khubchandani, D. J. Lovell, K. M. O'Neil, P. Quartier, A. Ravelli, S. M. Iusan, G. Filocamo, C. S. Magalhaes, E. Unsal, S. Oliveira, C. Bracaglia, A. Bagga, V. Stanevicha, S. M. Manzoni, P. Pratsidou, L. Lepore, G. Espada, I. Kone-Paut, F. Zulian, P. Barone, Z. Bircan, R. Maldonado Mdel, R. Russo, I. Vilca, K. Tullus, R. Cimaz, G. Horneff, J. Anton, S. Garay, S. Nielsen, G. Barbano and A. martini: EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: overall methodology and clinical characterisation. Ann Rheum dis, 69(5), 790-7 (2010). https://doi.org/10.1136/ard.2009.116624.

Eleftheriou D, Batu ED, Ozen S, Brogan PA. Vasculitis in children. Nephrol Dial Transplant. 2015;30(Suppl 1):i94–103. https://doi.org/10.1093/ndt/gfu393.CrossRefPubMed

Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schonlein nephritis. Pediatr Nephrol. 2007;22(1):64–70. https://doi.org/10.1007/s00467-006-0278-0.CrossRefPubMed

Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, R. C. Monteiro and M. van Egmond: new insights in the pathogenesis of immunoglobulin a vasculitis (Henoch-Schonlein purpura). Autoimmun Rev. 2017;16(12):1246–53. https://doi.org/10.1016/j.autrev.2017.10.009.CrossRefPubMed

Diaz JM, Gonzalez AM, Alonso REB, Brunen JMG, Repiso GA. Food-induced IgA Vasculitis (Henoch-Schonlein Purpura). Eur J Case Rep Intern Med. 2018;5(2):000774. https://doi.org/10.12890/2017_000774.CrossRefPubMedPubMedCentral

Lagier JC, Khelaifia S, Alou MT, Ndongo S, Dione N, Hugon P, et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol. 2016;1:16203. https://doi.org/10.1038/nmicrobiol.2016.203.CrossRefPubMed

Evenepoel P, Poesen R, Meijers B. The gut-kidney axis. Pediatr Nephrol. 2017;32(11):2005–14. https://doi.org/10.1007/s00467-016-3527-x.CrossRefPubMed

Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(4):1125–1136.e8. https://doi.org/10.1016/j.cell.2016.10.020.CrossRefPubMedPubMedCentral

10.

Planer JD, Peng Y, Kau AL, Blanton LV, Ndao IM, Tarr PI, et al. Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice. Nature. 2016;534(7606):263–6. https://doi.org/10.1038/nature17940.CrossRefPubMedPubMedCentral

11.

S. Tao, L. Li, L. Li, Y. Liu, Q. Ren, M. Shi, J. Liu, J. Jiang, H. Ma, Z. Huang, Z. Xia, J. Pan, T. Wei, Y. Wang, P. Li, T. Lan, X. Tang, X. Zeng, S. Lei, H. Tang and L. Ma: Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition, 56(5), 581–592 (2019). https://doi.org/10.1007/s00592-019-01316-7.

12.

Y. Li, X. Su, L. Zhang, Y. Liu, M. Shi, C. Lv, Y. Gao, D. Xu and Z. Wang: Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case-controlled study, 17(1), 228 (2019). https://doi.org/10.1186/s12967-019-1969-1.

13.

Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. Interactions between intestinal microbiota and host immune response in inflammatory bowel disease. Front Immunol. 2017;8:942. https://doi.org/10.3389/fimmu.2017.00942.CrossRefPubMedPubMedCentral

14.

Xu KY, Xia GH, Lu JQ, Chen MX, Zhen X, Wang S, et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep. 2017;7(1):1445. https://doi.org/10.1038/s41598-017-01387-y.CrossRefPubMedPubMedCentral

15.

Johnson CC, Ownby DR. The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Transl Res. 2017;179:60–70. https://doi.org/10.1016/j.trsl.2016.06.010.CrossRefPubMed

16.

De Angelis M, Montemurno E, Piccolo M, Vannini L, Lauriero G, Maranzano V, et al. Microbiota and metabolome associated with immunoglobulin a nephropathy (IgAN). PLoS One. 2014;9(6):e99006. https://doi.org/10.1371/journal.pone.0099006.CrossRefPubMedPubMedCentral

17.

Hu X, Du J, Xie Y, Huang Q, Xiao Y, Chen J, et al. Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study. BMC Nephrol. 2020;21(1):97. https://doi.org/10.1186/s12882-020-01741-9.CrossRefPubMedPubMedCentral

18.

Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum. 1990;33(8):1114–21.CrossRefPubMed

19.

Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271–8. https://doi.org/10.1097/01.asn.0000013883.99976.22.CrossRefPubMed

20.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006.CrossRefPubMedPubMedCentral

21.

Faul F, Erdfelder E, Lang AG, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91. https://doi.org/10.3758/bf03193146.CrossRefPubMed

22.

Wang J, Guo P, Gao Z, Zhou B, Ren L, Chen Y, et al. Elevated bilirubin levels and risk of developing chronic kidney disease: a dose-response meta-analysis and systematic review of cohort studies. Int Urol Nephrol. 2018;50(2):275–87. https://doi.org/10.1007/s11255-017-1675-y.CrossRefPubMed

23.

Andrade-Oliveira V, Amano MT, Correa-Costa M, Castoldi A, Felizardo RJ, de Almeida DC, et al. Gut Bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol. 2015;26(8):1877–88. https://doi.org/10.1681/asn.2014030288.CrossRefPubMedPubMedCentral

24.

Chen YH, Bai J, Wu D, Yu SF, Qiang XL, Bai H, et al. Association between fecal microbiota and generalized anxiety disorder: severity and early treatment response. J Affect Disord. 2019;259:56–66. https://doi.org/10.1016/j.jad.2019.08.014.CrossRefPubMed

25.

Xiao C, Xiao P, Li X, Huang G, Li H, Chen Y. Streptococcus may aggravate inflammatory damage in chronic nephritis via the chemotaxis of Th22 cells. Am J Transl Res. 2019;11(12):7432–40.PubMedPubMedCentral

26.

Zhu Y, He C, Li X, Cai Y, Hu J, Liao Y, et al. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice. J Gastroenterol. 2019;54(4):347–58. https://doi.org/10.1007/s00535-018-1529-0.CrossRefPubMed

27.

Z. X. Zhong, J. X. Tan, Y. Tang, L. Tan, G. Q. Pei and W. Qin: Crescent lesions are not a predictive factor in adult-onset Henoch-Schonlein purpura nephritis, 19(4), 449–456 (2019). https://doi.org/10.1007/s10238-019-00567-6.

28.

Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, et al. Persistent hematuria and kidney disease progression in IgA nephropathy: a cohort study. Am J Kidney Dis. 2020. https://doi.org/10.1053/j.ajkd.2019.11.008.

29.

E. A. Bertola, G. D. Simonetti, R. Del Giorno, O. Giannini, E. F. Fossali, M. Meoli, M. G. Bianchetti and B. Terziroli Beretta-Piccoli: Extrarenal Immune-Mediated Disorders Linked with Acute Poststreptococcal Glomerulonephritis: a Systematic Review, 57(2), 294–302 (2019). https://doi.org/10.1007/s12016-019-08761-w.

30.

Dietrich ML, Steele RW. Group a Streptococcus. Pediatr Rev. 2018;39(8):379–91. https://doi.org/10.1542/pir.2017-0207.CrossRefPubMed

31.

Coppo R. The gut-renal connection in IgA nephropathy. Semin Nephrol. 2018;38(5):504–12. https://doi.org/10.1016/j.semnephrol.2018.05.020.CrossRefPubMed

32.

Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. Isme j. 2016;10(3):742–50. https://doi.org/10.1038/ismej.2015.151.CrossRefPubMed

33.

Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23(3):402–14. https://doi.org/10.1097/EDE.0b013e31824d5da2.CrossRefPubMed

34.

Tao S, Tao S, Cheng Y, Liu J, Ma L, Fu P. Effects of probiotic supplements on the progression of chronic kidney disease: a meta-analysis. Nephrology (Carlton). 2019;24(11):1122–30. https://doi.org/10.1111/nep.13549.CrossRef

35.

Chemouny JM, Gleeson PJ, Abbad L, Lauriero G, Boedec E, Le Roux K, et al. Modulation of the microbiota by oral antibiotics treats immunoglobulin a nephropathy in humanized mice. Nephrol Dial Transplant. 2019;34(7):1135–44. https://doi.org/10.1093/ndt/gfy323.CrossRefPubMed

Title: Intestinal dysbiosis featuring abundance of Streptococcus associates with Henoch-Schönlein purpura nephritis (IgA vasculitis with nephritis) in adult
Authors: Jiaxing Tan
Zhengxia Zhong
Yi Tang
Wei Qin
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: IgA Vasculitis
IgA Vasculitis
Escherichia Coli
Streptococci
Respiratory Microbiota
Published in: BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI: https://doi.org/10.1186/s12882-021-02638-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Intestinal dysbiosis featuring abundance of Streptococcus associates with Henoch-Schönlein purpura nephritis (IgA vasculitis with nephritis) in adult

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Hemodialysis patients’ satisfaction with dialysis care: a cross-sectional prospective study conducted in a non-profitable care facility, Minia Egypt

Characteristics and predictors of mortality on haemodialysis in Brazil: a cohort of 5,081 incident patients

Identification and validation of glomerulotubular crosstalk genes mediating IgA nephropathy by integrated bioinformatics

The rate, cost and outcomes of parathyroidectomy in the united states dialysis population from 2016–2018

A potential link between AQP3 and SLC14A1 gene expression level and clinical parameters of maintenance hemodialysis patients

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page